BLRX Key Stats
- BioLineRx Closes $24.1 Million Underwritten Public Offering of its American Depositary Shares noodls 03/07 13:33 ET
- BioLineRx (BLRX) Closes 9.66M ADS Offering for Gross Proceeds of $24.1M Street Insider 03/07 12:07 ET
- OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 6.8% - Tale of the Tape Zacks 03/06 08:51 ET
- OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 6.8% Yahoo 03/06 01:33 ET
- Portola Pharmaceuticals (PTLA) Jumps: Stock Up 8.3% - Tale of the Tape Zacks 03/05 08:51 ET
- BioLineRx to Present at the Annual ROTH Growth Stock Conference in California noodls 03/05 07:19 ET
- BioLineRx Prices $21.0 Million Underwritten Public Offering of its American Depositary Shares noodls 03/05 03:34 ET
- Portola Pharmaceuticals (PTLA) Jumps: Stock Up 8.3% Yahoo 03/05 00:35 ET
- Unusual 11 Mid-Day Movers 03/04: (VIPS) (INSY) (FCEL) Higher; (ZIPR) (AETI) (RSH) Lower Street Insider 03/04 12:43 ET
- Pre-Open Stock Movers 3/4: (OXBT) (VIPS) (INSY) Higher; (RSH) (MDR) (MDRL) Lower (more...) Street Insider 03/04 09:31 ET
BLRX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Bioline Rx is down 37.75% over the last year vs S&P 500 Total Return up 24.21%, Actelion up 98.29%, and Aratana Therapeutics up N/A.
Balance Sheet View Statement
Pro Ratings for BLRX
Pro Strategies Featuring BLRX
Did Bioline Rx make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: Israel
- Headquarters State/Province: N/A
- Incorporation Country: Israel
- Incorporation State/Province: N/A
Bioline Rx Ltd., is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds in areas of central nervous system, oncology, cardiovascular, & infectious diseases, among others.